Workflow
Kura Oncology Transitioning To Commercial Stage: Why I Choose To Buy

Kura Oncology, Inc. (NASDAQ: KURA ) stock is having a good month and is now on double-digit gains, although still trading slightly above its 52-week lower range. I believe the market is responding to the fast-approaching U.S. Food andGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital markets, and the macro-economy, G ...